Jiaxin Liao

Jiaxin Liao

Auto-generated profile, based on publicly available information

Jiaxin Liao

Department of Endocrinology, The Huai'an Hospital Affiliated to Xuzhou Medical University and The Second People's Hospital of Huai'an, Xuzhou Medical University, Huai'an, People's Republic of China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2023 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
JLJiaxin Liao
Jiaxin Liao
YLYuting Li
Yuting Li
XGXiaoting Gui
Xiaoting Gui
YZYong Zhang
Yong Zhang
XHXu Hu
Xu Hu
FBFeng Bai
Feng Bai
Purpose: This study aimed to investigate the relationship between serum isthmin-1 (ISM1) and type 2 diabetes mellitus (T2DM), and the alteration of serum ISM1 level in both diabetic sensorimotor peripheral neuropathy (DSPN) and diabetic adults with obesity. Patients and Methods: We recruited 180 participants (120 T2DM and 60 controls) in the cross-sectional study. First, we compared the serum ISM1 concentration in diabetic patients and non-diabetic controls. Secondly, according to DSPN, patients were divided into DSPN and non-DSPN groups. Last, patients were categorized as lean T2DM (15 males, 15 females), overweight T2DM (35 males, 19 females), and obese T2DM groups (23 males, 13 females) according to gender and body mass index (BMI). All participants were collected with clinical characteristics and biochemical profiles. Serum ISM1 was detected in all subjects by ELISA. Results: Higher serum ISM1 [7.78 ng/mL (IQR: 6.33– 9.06) vs 5.22 (3.86– 6.04), P < 0.001] was observed in diabetic patients compared to non-diabetic controls. Binary logistic regression analysis showed that serum ISM1 was a risk factor for type 2 diabetes after adjustment (OR=4.218, 95% CI: 1.843– 9.653, P=0.001). Compared to the non-DSPN group, serum ISM1 level was not changed significantly in patients who suffered from DSPN. Diabetic females with obesity had lower level of serum ISM1 (7.10± 1.29 ng/mL) when compared to the lean T2DM (8.42± 1.36 ng/mL, P < 0.05) and the overweight T2DM (8.33± 1.27 ng/mL, P < 0.05). However, serum ISM1 was not changed significantly in male groups or all patients together. Conclusion: Serum ISM1 was a risk factor for type 2 diabetes, and it was associated with diabetic adults with obesity while there was sexual dimorphism. However, serum ISM1 levels were not correlated with DSPN.

27 April 2018 in Supramolecular Chemistry
Verified
Journal Article
Closed access
RQRui Qiao
Rui Qiao
WXWen-Zhang Xiong
Wen-Zhang Xiong
CBCui-Bing Bai
Cui-Bing Bai
JLJia-Xin Liao
Jia-Xin Liao
LZLin Zhang
Lin Zhang
A new fluorescent probe L based on the rhodamine 6G platforms for Fe3+ has been designed and synthesised. L showed excellent selectivity and high sensitivity for Fe3+ against other metal ions such as K+, Na+, Ag+, Cu2+, Co2+, Mg2+, Cd2+, Ni2+, Zn2+, Fe2+, Hg2+, Ce3+ and Y3+ in HEPES buffer (10 mM, pH 7.4)/CH3CN (40:60, V/V). The distinct color change and the rapid emergence of fluorescence emission provided naked-eyes detection for Fe3+. The recognition mechanism of the probe toward Fe3+ was evaluated by Job’s plots, IR and ESI-MS. In order to further study their fluorescent properties, L + Fe3+ fluorescence lifetime was also measured. Moreover, the test strip results showed that these probes could act as a convenient and efficient Fe3+ test kit.